openPR Logo
Press release

HIV Drug / Medicine Market is expected to reach at notable revenue of around USD 38.1 Billion by the end of 2023

05-18-2018 09:07 AM CET | Health & Medicine

Press release from: Research Nester Pvt Ltd

HIV Drug / Medicine Market is expected to reach at notable revenue

HIV Drug market is one of the growing drug markets across the globe. There has been a significant rise in number of HIV population worldwide. On the other hand, increase in number of cases of infection transmission through contaminated needles or infected blood has been registered in last few years. Breast milk, unprotected sex is the most common & big route of HIV to infect a large number of population across the globe and decrease the immunity of protection against infections.

Several government initiatives have been started and awareness programs are entertained in order to minimize the burden of HIV across the globe. Improvements in medicinal therapies like antiretroviral therapy (ART) which are also affordable for the patients suffering from HIV helps in the overall care and also increasing life expectancy of the patients. In 2014, 25 antivirals, 16 vaccines and 3 gene therapies have been introduced in the U.S. to improve treatment facilities with better and effective cure. Several drugs have been recently licensed for the treatment of HIV-1 infected patients. These new drugs include CCR5 co-receptor antagonist which is using for the patients those have developed resistance from previous drugs and therapies.

New developments and introduction of effective and affordable therapies is expected to expand the demand for HIV drugs over the forecast period i.e. 2015-2023.

Market size and forecast

The HIV Drug market is expected to expand at a CAGR of 5.93% during the forecast period 2015-2023. The HIV Drug market is expected to reach USD 38.01 Billion by 2023 from USD 26.9 Billion in 2015.

Request Free Report Sample@ https://www.researchnester.com/sample-request/2/rep-id-162

The U.S. is expected to showcase a lucrative growth in HIV Drug market in the forecast period and HIV Drug market is expected to reach USD 2.2 Billion during the forecast period i.e. 2015-2023 in the region. HIV Drug market is expected to expand at a rapid pace over the forecast period 2015-2023 due to introduction of new and effective drugs with less side-effect which will spur the demand for HIV drugs across the globe.

Market Segmentation

Global HIV Drug Market is further segmented on the basis of drugs type as follows:

Demand Analysis By Original Drugs

Demand Analysis By Generic Drugs

Demand Analysis By Drugs Type

Multi class combination products
Nucleoside reverse transcriptase inhibitors
Non-nucleoside reverse transcriptase inhibitors
Entry inhibitors - CCR5 co-receptor antagonist
Fusion inhibitors
Protease inhibitors
HIV integrase strand transfer inhibitors

Growth Drivers and challenges

Lack of awareness in under developed nations towards protected sex is likely to further raise the population suffering from HIV which is further believed to increase the growth of HIV drug market across the globe during the forecast period 2015-2023. Advancement in healthcare and drug technology due to huge funding in Research and Development sector would help the companies to develop more effective drugs to restrict the dysfunctions and loss of immunity in the human body and is expected to grow the demand of HIV drug and further enforce the market of HIV drug globally.Further, governmental initiatives and rising awareness towards HIV and its carrier is anticipated to propel the demand for HIV drug market over the forecast period 2015-2023 globally. Apart from this, huge funding from the governmental authorities to provide better facilities and cure at affordable cost will make buyers to adopt the precautions related to HIV which is expected to propel further expand the demand of HIV drug market globally. Availability of Anti-retroviral Therapy (ART) with efficient fixed-dose combination reduces the burden of taking excess of pills to keep the infection inactive on the human body which helps the patients to opt these therapies with minimized number of dose. These therapies are expected to grow the demand of HIV Drug over the forecast period i.e. 2015-2023.

Request Free Table of Contents Here: https://www.researchnester.com/toc-request/1/rep-id-162

However, lack of availability of better and effective cure for HIV in low income countries would be a challenge for the HIV drug market during the forecast period. It has been notified that major population of HIV infected people is present in Sub-Saharan Africa region where the healthcare facilities are expensive for most of the population due to low disposable income which is expected to hinder the growth of HIV drug market.

Generic drugs present in the market are not affordable for the population of low income nations as manufacturing of drugs through original patents is expected to raise the cost of HIV drugs which would be a huge restraint for the HIV drug market. Addioitnally, experiencing treatment failure in several therapies of fixed dose due to development of resistance or toxicity in the body is a major burden and restraint for the HIV Drug market across the globe.

This report also provides the existing competitive scenario of some of the key players of the global HIV drug / medicine market which includes company profiling of GlaxoSmithKline PLC., Merck & Co., Inc., Johnson and Johnson, Hetero Drugs Limited, Gilead Sciences, Cipla Limited, Abbott Laboratories, Pfizer Inc., ViiV Healthcare and Macleods Pharmaceuticals Ltd. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global HIV drug / medicine market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.

Read more Information: https://www.researchnester.com/reports/hiv-drug-medicine-market-global-demand-analysis-opportunity-outlook-2023/162

About Research Nester

Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision so as to avoid future uncertainties.

Contact for more Info:                                           

Ajay Daniel

Email: ajay.daniel@researchnester.com

U.S. +1 646 586 9123

U.K. +44 203 608 5919

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release HIV Drug / Medicine Market is expected to reach at notable revenue of around USD 38.1 Billion by the end of 2023 here

News-ID: 1054231 • Views:

More Releases from Research Nester Pvt Ltd

Chemical Fertilizers Market Outlook By Industry Size, Share, Revenue, Regions And Top Key Players Analysis From 2017-2024
Chemical Fertilizers Market Outlook By Industry Size, Share, Revenue, Regions An …
The chemical fertilizers market has been segmented into macronutrients, micronutrients, application and forms. Based on macronutrients, the market has been segmented into nitrogen based fertilizers, phosphate based fertilizers and potash based fertilizers. Among these segments, the nitrogen based fertilizers are estimated to dominate the market by holding the largest share of approximately 50%. This can be attributed to the absorption of nitrogen by plants. In 2013, the demand for nitrogen
Glass Coating Market Overview By Share, Size, Industry Players, Revenue And Product Demand Forecast Till 2027
Glass Coating Market Overview By Share, Size, Industry Players, Revenue And Prod …
The global glass coating market is segmented by coating type into pyrolytic coating, magnetic sputtering coating and sol-gel coating; by technology into liquid glass coating and nano glass coating; by application into construction, paints & coating, automotive, aviation and others and by regions. According to Federal Reserve Bank of Chicago represents increase in sales of light vehicle in China by 2.1%, Latin America by 6.2%, Europe by 2.6%, and Rest
Insect Repellent Market Outlook By Industry Size, Share, Revenue, Regions And Top Key Players Analysis From 2019-2027
Insect Repellent Market Outlook By Industry Size, Share, Revenue, Regions And To …
The global insect repellent market is segmented by repellent type into coils, liquid vaporizers, sprays/aerosol, mats, cream and oil; by ingredient into natural and synthetic; by sales channel into online and offline and by regions. The insect repellent market is anticipated to mask a CAGR of 8.3% during the forecast period i.e. 2019-2027. The rising penetration of insect repellents in untapped rural markets across the developing countries as well as
Waterproofing Chemicals Market 2017 Share Growing Rapidly With Latest Trends, Development, Revenue, Demand And Forecast To 2027
Waterproofing Chemicals Market 2017 Share Growing Rapidly With Latest Trends, De …
The global waterproofing market is segmented on the basis of type, application and end-use. The market is segmented on the basis of type, it is segmented into Bitumen, PVC, TPO and EPDM. Bitumen leads the product segment in 2017 on the account of superior properties which include high viscosity, resistance to UV light and better binding nature. On the basis of application, it is segmented into Roofing and Walls, Flooring,

All 4 Releases


More Releases for HIV

HIV-Associated Lipodystrophy Treatment Market - Increasing prevalence of HIV is …
HIV-associated lipodystrophy also known as lipodystrophy is a syndrome that occurs in HIV-infected patients. It is characterized by loss of subcutaneous fat from face, buttocks, arms and legs. Although the exact cause of HIV-associated lipodystrophy is not fully elucidated, some research evidence reported that it occurs in HIV-infected patients who are under antiretroviral medications. According to an article published in National Center for Biotechnology Information (NCBI) in 2014, prevalence of
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication
HIV Therapeutics Market– South Africa's Aspen launches three-in-one HIV drug
Recent Developments Aspen Pharma care, a South Africa’s drug maker has launched a triple combination of tablet for the treatment of HIV in the country where the HIV virus is the most prevalent. The company's new Emdolten drug is a once a day tablet which is in the form of dolutegravir, an antiretroviral medication that balances the drug’s resistance. The company has launched Aspen Stavudine which was its first generic ARV
HIV Vaccine Market HIV Vaccine Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents Introduction to Human Immunodeficiency Virus (HIV) Vaccines 1.1 Overview 1.2 Antiquity of HIV Vaccine Need for the Development of HIV Vaccine Primer of HIV inside the Body 3.1 Inclusion of HIV Virus into the System 3.2 Interaction of HIV with Host 3.3 Eradication of HIV Virus HIV Vaccine Development Process 4.1 Introduction
Global HIV Vaccine Market & HIV Vaccine Clinical Trial Outlook 2022
Worldwide, around the 35 Million of the people are currently infected with the HIV and about 30 Million of the people died because of the AIDS infection. There is no human example of clearing an HIV infection naturally. HIV virus makes copies of it very quickly, many types of HIV exist and new types of virus are continue to rise. Many scientists are still trying to understand the specific ways
Hidden HIV Revealed: New Insights Into Latent HIV Infections
In spite of ever more effective therapies, HIV keeps managing to survive in the body. A comprehensive project conducted by the Austrian Science Fund FWF has clarified the molecular processes which contribute to this effect. In the process, approaches were discovered for possible therapies to combat the hidden reservoir formed by the virus. Thanks to modern therapies, HIV infections have become controllable – but these treatments cannot provide a cure. Antiretroviral